Who
J. Jefferson Smith
Chief Research Officer
Company insider
Files Form 4 as: Chief Research Officer, Precision BioSciences.
In numbers
- Trades disclosed
- 51
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $183K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jan 2023
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,389 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,389 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $19K4,925 at $3.84 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $19K4,925 at $3.84 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —16,667 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,667 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,667 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —16,667 at $0.00 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —16,219 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $41K10,200 at $4.03 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —16,219 | filing |
| 21 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $41K10,200 at $4.03 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —2,500 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —10,447 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,447 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,219 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,447 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,219 at $0.00 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name J. Jefferson Smith; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.